MAPT and Parkinson disease: Moreover, up to 50% of PD patients with dementia also develop sufficient numbers of β-amyloid plaques and tau-containing neurofibrillary tangles, These pathological changes may interact synergistically with α-synuclein pathology, potentially contributing to a poorer prognosis (Irwin et al., 2013).